HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm

NCT00076817 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test the Safety of Three Experimental HIV Vaccines

NCT00000946 ·Status: COMPLETED ·Phase: PHASE1

Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144

NCT01435135 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

NCT00000904 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

NCT00007332 ·Status: COMPLETED ·Phase: PHASE2

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

NCT00001052 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants

NCT03122223 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda

NCT00007423 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Safety Study of Two Experimental HIV Vaccines

NCT00479999 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

NCT00027261 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

NCT00001044 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection

NCT00709605 ·Status: COMPLETED ·Phase: PHASE1

Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E

NCT01931358 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

NCT00000868 ·Status: COMPLETED ·Phase: PHASE1

Vaccine Treatment for HIV-Infection

NCT00108654 ·Status: COMPLETED ·Phase: PHASE1

Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers

NCT00122564 ·Status: TERMINATED ·Phase: PHASE1

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

NCT00001096 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

NCT03878121 ·Status: RECRUITING ·Phase: PHASE1

HIV Vaccine Trial in Thai Adults

NCT00223080 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

NCT00011011 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC

NCT00026624 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

NCT00415649 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

NCT00000779 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

NCT00472719 ·Status: COMPLETED ·Phase: PHASE1